Omnicell
OMCL
279 hedge funds and large institutions have $3.07B invested in Omnicell in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 114 increasing their positions, 95 reducing their positions, and 47 closing their positions.
550% more call options, than puts
Call options by funds: $7.7M | Put options by funds: $1.19M
20% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 95
1.57% more ownership
Funds ownership: 100.28% → 101.85% (+1.6%)
7% less funds holding
Funds holding: 299 → 279 (-20)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
14% less capital invested
Capital invested by funds: $3.55B → $3.07B (-$488M)
40% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 47
Top Buyers
Top Sellers
OMCL Hedge Fund Activity: Q3 2019 in Review
279 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q3 2019, worth a combined $3.07B — down 14% from $3.55B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of OMCL and 28 opened new positions — a net loss of 19 holders — while 95 trimmed existing stakes and 114 added.
The largest buyer was Credit Suisse, adding an estimated $45.9M. The largest seller was Copper Rock Capital Partners, exiting entirely with an estimated $19.9M sold.
- 279 institutional investors held Omnicell (OMCL) as of Q3 2019, down from 299 in Q2 2019.
- Funds reported $3.07B of Omnicell stock for Q3 2019, down 14% quarter-over-quarter.
- 28 funds opened new Omnicell positions in Q3 2019 and 47 closed out, a net change of -19 holders.
- The largest Omnicell buyer in Q3 2019 was Credit Suisse, an estimated $45.9M added.
- The largest Omnicell seller in Q3 2019 was Copper Rock Capital Partners, an estimated $19.9M sold.
Based on aggregated 13F filings for Q3 2019.